Features Partner Sites Information LinkXpress
Sign In

PET/CT and CT Technology Designed for Real-Time Collaboration Between Clinicians

By Medimaging International staff writers
Posted on 09 Dec 2013
Print article
Image: The Vereos PET/CT fully digital imaging system (Photo courtesy of Philips Healthcare).
Image: The Vereos PET/CT fully digital imaging system (Photo courtesy of Philips Healthcare).
A digital positron emission tomography/computed tomography (PET/CT) imaging system and spectral detector-based computed tomography (CT) imaging system have been designed to provide optimal image quality, vital data, and connectivity for real-time collaboration among clinicians and fast, effective decision making.

At the 99th annual meeting of the Radiological Society of North America (RSNA), held December 1–6, 2013, in Chicago (IL, USA), Philips Healthcare (Best, The Netherlands) presented new medical imaging technology with the introduction of two new developments: its Vereos PET/CT fully digital imaging system, and its IQon Spectral CT1 spectral detector-based CT imaging system.

Philips collaborates with clinicians to enhance the clinical performance and economic cost-effectiveness of its technology to find the shortest path to the best care with the most efficient use of resources. “We work closely with radiologists to understand their biggest challenges, and incorporate these understandings in the development of innovative products like Vereos PET/CT and IQon Spectral CT to meet their complex imaging needs,” said Gene Saragnese, CEO, imaging systems at Philips Healthcare. “These innovations demonstrate how Philips is providing radiologists with exceptional quality and accuracy in imaging at low dose rates, helping clinicians to get answers, the first time around, so that they can deliver accurate and more confident diagnoses to patients.”

“The timing and precision of disease diagnosis are critical to the successful treatment of many diseases,” commented Pablo Ros, MD, chairman of the department of radiology, University Hospitals Case Medical Center and Case Western Reserve University (Cleveland, OH, USA). “With that in mind, we are excited to have contributed to the development of Philips’ Vereos digital PET/CT and IQon Spectral CT systems and we will continue to collaborate with Philips to realize the potential of these next generation imaging systems.”

Based on Philips’ proprietary Digital Photon Counting technology, the Vereos PET/CT is the first PET/CT system in the industry to use novel digital silicon photomultiplier detectors instead of standard analog detectors, resulting in better performance, including approximately two-times increase in sensitivity gain, volumetric resolution, and quantitative accuracy when compared to analog systems. These enhancements provide high image quality, increased diagnostic effectiveness, improved treatment planning, and faster workflows.

“Personalized medicine will require a patient-specific picture of the functional processes associated with disease,” added Dr. Ros. “Accurate quantification of processes is therefore an important requirement for functional imaging in diagnosis, therapy, and research. The quantitative accuracy and remarkably clear images that the new digital PET/CT system delivers are a key step forward.”

In a recent survey, 9 out of 10 referring physicians preferred Vereos digital PET/CT images to images taken with an analog system. Philips has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its digital PET/CT system in the United States.

Philips’ IQon Spectral CT system employs color to identify the composition of an image without involving time-consuming protocols. Similar to the way that white light is made up of a spectrum of colors, the X-ray beam used in CT scanners also consists of a spectrum of X-ray energies. With the development of an essentially new spectral detector that can differentiate between X-ray photons of multiple high and low energies simultaneously, Philips’ IQon Spectral CT adds new levels to CT imaging, offering not only anatomic data but also the ability to characterize structures based on their material composition within only one scan.

After a spectral CT examination, clinicians can interpret the conventional grey-scale anatomical images, and if necessary, access the spectral information that was acquired during the same scan. The IQon Spectral CT system’s retrospective on-demand data analysis is possible utilizing the Philips’ iPatient platform, allowing clinicians to easily experience the advantages of spectral CT routinely within traditional radiology workflows.

CT imaging is widely used in the diagnosis of many different diseases and injuries, totaling approximately 450 million imaging procedures globally yearly. Philips has consistently driven innovation in CT, most recently with the introduction of its proprietary iterative model reconstruction (IMR) technology to simultaneously reduce CT radiation dose and enhance image quality for a broad range of applications.

The IQon Spectral CT is pending US Food and Drug Administration (FDA) 510(k) and is not yet available for sale in the United States. A system with the NanoPanel Prism detector is available for sale in the United States for conventional scanning.

Related Links:

Philips Healthcare

Print article



view channel

Additional Aggressive Cancers Can Be Found Using Breast MRI Following Mammography Screening

The results of a study published online in the journal Radiology have shown that performing MRI scans, after the discovery of mammography breast cancer findings, sometimes shows larger and more aggressive tumors than those discovered in mammography. Breast Magnetic Resonance Imaging (MRI) is widely used for the screening... Read more


view channel
Image: The connected Lumify with two advanced ultrasound transducers (Photo courtesy of Royal Philips).

Ultraportable Ultrasounds Plug into a Smartphone

Advanced hand-held ultrasound (US) transducers and an app-based online portal and subscription platform provide a comprehensive, connected digital imaging solution. The Philips Lumify is a complete... Read more

Nuclear medicine

view channel
Image: Glioblastoma in a PET scanner with (left) and without (right) the YY146 marker (Photo courtesy of Weibo Cai, WISC).

Antibody Cancer Marker Causes Tumors to Light Up

A novel marker attaches to a molecule on highly aggressive brain cancer, resulting in glioblastoma tumor tissue being easily identified in a positron emission tomography (PET) scanner. Developed by... Read more

Imaging IT

view channel

Rebuilt Web-Version of Free Mobile Healthcare Network Launched

A new, redesigned web version of a free mobile-first network, that enables radiologists and other healthcare professionals to view and share medical cases, has been launched and is slated to be showcased at the annual meeting of the Radiological Society of North America (RSNA 2015) during November 29–December 4, 2015).... Read more

Industry News

view channel

Long-Term Strategic Managed Medical Equipment Services Partnership Announced

An 18-year strategic collaboration agreement, worth CAD 300 million, between a major medical imaging vendor and the Southwest York Region of Ontario in Canada, has been announced. The partnership is for managed equipment services to help advance medical technology in the Southwest York region, and to expand the accessibility... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.